Biosimilars 2014
Clinical topics, quality requirements & vigilance aspects
-
Clinical topics, quality requirements & vigilance aspects50.0588473 8.5890426
| Wann |
04.07.2013 um 09:00 bis 05.07.2013 um 15:30 |
|---|---|
| Veranstaltungsort | Steigenberger Airport Hotel |
| Stadt | Frankfurt |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500-680 |
| Zielgruppe |
This seminar addresses the needs of managers in the pharmaceutical industry. Especially those working in the following areas will benefit from this event: marketing authorisation, clinical & preclinical trials, quality & analytics, business development and law. |
| Termin übernehmen |
vCal
iCal
|
We would like to give you a thorough update on the new challenges and opportunities arising in connection with the revision of the overarching biosimilar guideline and the upcoming further guidelines/revisions. We would like to discuss with you the clinical topics, as well as the quality requirements and vigilance aspects. After having completed the seminar you will be familiar with the current regulatory requirements and have a good insight into the European, US and worldwide biosimilars development programmes, recognising that each region has its own challenges and opportunities. May we invite you to a firsthand update?
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
